Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device
NCT00607529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99
Last updated 2010-06-04
Summary
This study is being done to see if the Nova Creatinine Meter can give a correct measure of creatinine (a blood test used to measure kidney function) when the blood is taken from a capillary (smallest type of blood vessels). The Nova Creatinine Meter is a hand held device that can be used in a clinic to measure creatinine in about 50 seconds. Current laboratory creatinine testing can take up to an hour. Since chemotherapy patients need to have their creatinine measured prior to treatment, this meter could make testing easier and faster.
Conditions
Interventions
- OTHER
-
hand-held POC creatinine analyzer-blood test
This study will require the collection of a finger-puncture capillary blood specimen in addition to one green stoppered heparin containing collection tube. This is taken pre-therapy. The capillary whole blood specimen will be used to perform a creatinine determination on the "investigational" hand-held creatinine analyzer using special test strips for the analysis.
Sponsors & Collaborators
-
Nova Biomedical Corporation
collaborator INDUSTRY -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Martin Fleisher, PhD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
Countries
- United States
Study Locations
More Related Trials
-
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
NCT06744296 ·Status: RECRUITING
-
Biomarker Identification for Bladder Cancer Patients
NCT02053662 ·Status: TERMINATED
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma
NCT01173445 ·Status: COMPLETED
-
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT06995898 ·Status: RECRUITING ·Phase: NA
-
Cancer DNA Detection in Blood and Urine
NCT02657863 ·Status: COMPLETED
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
NCT06606028 ·Status: RECRUITING
-
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
NCT01187602 ·Status: UNKNOWN
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT00026884 ·Status: RECRUITING
-
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
NCT00806650 ·Status: COMPLETED
-
A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
NCT06630429 ·Status: ACTIVE_NOT_RECRUITING
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
NCT00900276 ·Status: COMPLETED
-
Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers
NCT00899769 ·Status: COMPLETED
-
Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma
NCT02732652 ·Status: COMPLETED
-
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
NCT06717295 ·Status: RECRUITING
-
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
NCT02706652 ·Status: TERMINATED
-
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
NCT00349830 ·Status: RECRUITING
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types
NCT03869814 ·Status: RECRUITING
-
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
NCT07243067 ·Status: NOT_YET_RECRUITING